Sangamo Therapeutics
0 sources
Financials
0001628280-26-022029Sangamo Therapeutics
Summary
Sangamo Therapeutics is a business[1]. It ranks in the top 4% of business entities by monthly Wikipedia readership (334 views/month).[2]
Key Facts
- Sangamo Therapeutics is in the country of United States[3].
- Sangamo Therapeutics is in the country of US[4].
- Sangamo Therapeutics's instance of is recorded as business[5].
- Sangamo Therapeutics's instance of is recorded as public company[6].
- Sangamo Therapeutics's headquarters location is recorded as Richmond[7].
- Sangamo Therapeutics's stock exchange is recorded as Nasdaq[8].
- Sangamo Therapeutics's industry is recorded as biotechnology[9].
- 1995 marks the founding of Sangamo Therapeutics[10].
- Sangamo Therapeutics's official website is recorded as http://www.sangamo.com[11].
- Sangamo Therapeutics's legal form is recorded as Delaware corporation[12].
- Sangamo Therapeutics's legal form is recorded as XTIQ[13].
Body
Founding
1995 marks the founding of Sangamo Therapeutics[10].
Operations
Sangamo Therapeutics's headquarters location is recorded as Richmond[7].
Industry
Sangamo Therapeutics's industry is recorded as biotechnology[9].
Ownership
Sangamo Therapeutics's stock exchange is recorded as Nasdaq[8].
Why It Matters
Sangamo Therapeutics ranks in the top 4% of business entities by monthly Wikipedia readership (334 views/month).[2] It is known by 5 alternative names across languages and contexts.[14]